NBP
NovaBridge Biosciences
NASDAQ: NBP · HEALTHCARE · BIOTECHNOLOGY
$2.35
-1.67% today
Updated 2026-04-29
Market cap
$271.77M
P/E ratio
—
P/S ratio
25.39x
EPS (TTM)
$-0.48
Dividend yield
—
52W range
$1 – $7
Volume
0.9M
NovaBridge Biosciences (NBP) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $1.03B | $2.38B | $1.74B | $6.33B | $5.63B | $4.07B | $2.61B | $212.68M |
| Cash & equivalents | $307.93M | $1.59B | $1.14B | $4.76B | $3.52B | $3.21B | $2.14B | $68.26M |
| Current assets | $691.59M | $2.04B | $1.36B | $5.34B | $4.78B | $3.63B | $2.34B | $176.69M |
| Total liabilities | $1.33B | $3.33B | $3.77B | $706.65M | $1.04B | $1.07B | $894.81M | $11.52M |
| Current liabilities | $195.14M | $346.16M | $588.48M | $576.13M | $624.00M | $659.74M | $411.81M | $8.45M |
| Long-term debt | — | — | — | — | — | — | $8.31M | — |
| Shareholder equity | $-299.80M | $-955.10M | $-2.03B | $5.63B | $4.59B | $3.01B | $1.72B | $201.16M |
| Retained earnings | $-357.86M | $-1.01B | $-2.49B | $-2.02B | $-4.35B | $-6.77B | $-8.33B | $-1.29B |
| Accounts receivable | $628150.00 | $9.36M | $7.99M | $71.31M | $60.95M | $4.81M | $1.83M | $1.17M |
| Inventory | — | $-215.57M | $-55.87M | — | $4.27M | $-80.28M | $28.95M | — |
| Goodwill | $162.57M | $162.57M | $162.57M | $162.57M | $162.57M | $162.57M | $0.00 | — |